Incidence of thromboembolic events in testicular cancer patients receiving cisplatin (TESTCIS study)
{{output}}
IntroductionDespite the increased incidence of testicular cancer in men aged 15 to 35, patients with this neoplasm have a high five-year survival rate thanks to chemotherapy. However, cisplatin, a drug used in the standard treatment for testicular cancer, seem... ...
